EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma

Katariina Mähönen, Isabel Mogollon, Antti Hassinen, Minttu Polso, Katja Välimäki, Swapnil Potdar, Al-Amin Chowdhury, Annamari Ranki, Jani Saarela, Vilja Pietiäinen, Jaana Panelius

Acta Dermato-Venereologica · 03.08.2025 · 105 · adv43088

DOI: 10.2340/actadv.v105.43088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 03.08.2025. Verfasst von Katariina Mähönen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. katariina.mahonen@hus.fi. Hauptthemen laut MEDLINE: Scleroderma, Localized, Fibroblasts, Skin, Antifibrotic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Localized scleroderma is a rare autoimmune disease characterized by progressive fibrosis of the skin and its underlying structures, causing loss of normal tissue structure and function. Myofibroblasts, differentiated from fibroblasts by high expression of α-smooth muscle actin, play a key role in the pathogenesis with continuous production of collagen and other extracellular matrix components. Transforming growth factor β promotes myofibroblast transformation and is central to the pathogenesis of fibrotic diseases. Targeted therapies for skin fibrosis are lacking, and current treatment consisting of topical steroids and immunosuppressive drugs often has limited efficacy. In this study, testing was performed with 78 drugs on lesional localized scleroderma fibroblasts to find potential new therapies, with α-smooth muscle actin and collagen-1 expression as markers for antifibrotic effect. Several drugs belonging to inhibitors of tyrosine kinase, phosphoinositide-3 kinase, and transforming growth factor β receptor were found to have an antifibrotic effect in localized scleroderma fibroblasts. Along with increased expression of transforming growth factor β1, Smad3, and AKT found in lesional localized scleroderma skin, these results confirm transforming growth factor β pathway as a treatment target. Additionally, androgen receptor antagonists showed potential antifibrotic effects, co-aligning with an increased expression of androgen receptor in localized scleroderma skin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, LocalizedFibroblastsSkinAntifibrotic AgentsProtein Kinase InhibitorsHumansSmad3 ProteinCells, CulturedSignal TransductionTransforming Growth Factor beta1ActinsProto-Oncogene Proteins c-aktCollagen Type IFibrosisMaleFemaleAdultPrimary Cell CultureMiddle Aged

Substanzen

Smad3 ProteinSMAD3 protein, humanTransforming Growth Factor beta1ActinsProto-Oncogene Proteins c-aktCollagen Type IAntifibrotic AgentsTGFB1 protein, humanACTA2 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. katariina.mahonen@hus.fi.
  • Institute for Molecular Medicine Finland - FIMM, Helsinki Institute for Life Sciences - HiLIFE, University of Helsinki, Helsinki, Finland.
  • Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Zitieren

APA

Mähönen, K., Mogollon, I., Hassinen, A., Polso, M., Välimäki, K., Potdar, S., Chowdhury, A. A., Ranki, A., Saarela, J., Pietiäinen, V., & Panelius, J. (2025). High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma. Acta Dermato-Venereologica, 105, adv43088. https://doi.org/10.2340/actadv.v105.43088

Vancouver

Mähönen K, Mogollon I, Hassinen A, Polso M, Välimäki K, Potdar S, et al. High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma. Acta Dermato-Venereologica. 2025;105:adv43088. doi:10.2340/actadv.v105.43088

BibTeX
@article{Mhnen2025,
  author = {Mähönen, Katariina and Mogollon, Isabel and Hassinen, Antti and Polso, Minttu and Välimäki, Katja and Potdar, Swapnil and Chowdhury, Al-Amin and Ranki, Annamari and Saarela, Jani and Pietiäinen, Vilja and Panelius, Jaana},
  title = {High-content Image-based Drug Testing of Patients’ Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  volume = {105},
  pages = {adv43088},
  doi = {10.2340/actadv.v105.43088}
}
Kostenlos starten →